TransEnterix, Inc. (TRXC): Price and Financial Metrics

TransEnterix, Inc. (TRXC)

Today's Latest Price: $0.44 USD

0.02 (-3.82%)

Updated Aug 7 8:00pm

Add TRXC to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

TRXC Stock Summary

  • For TRXC, its debt to operating expenses ratio is greater than that reported by just 0.34% of US equities we're observing.
  • With a year-over-year growth in debt of -100%, Transenterix Inc's debt growth rate surpasses only 0% of about US stocks.
  • Revenue growth over the past 12 months for Transenterix Inc comes in at -67.7%, a number that bests merely 2.46% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to Transenterix Inc, a group of peers worth examining would be ALXN, COHR, JAZZ, RENN, and ANIP.
  • Visit TRXC's SEC page to see the company's official filings. To visit the company's web site, go to
TRXC Daily Price Range
TRXC 52-Week Price Range

TRXC Stock Price Chart Technical Analysis Charts

TRXC Price/Volume Stats

Current price $0.44 52-week high $14.43
Prev. close $0.46 52-week low $0.28
Day low $0.42 Volume 2,180,993
Day high $0.45 Avg. volume 3,744,123
50-day MA $0.49 Dividend yield N/A
200-day MA $1.18 Market Cap 22.81M

TransEnterix, Inc. (TRXC) Company Bio

TransEnterix, Inc. focuses on the development and commercialization of a robotic assisted surgical system in the United States and internationally. The company is based in Morrisville, North Carolina.

TRXC Latest News Stream

Event/Time News Detail
Loading, please wait...

TRXC Latest Social Stream

Loading social stream, please wait...

View Full TRXC Social Stream

Latest TRXC News From Around the Web

Below are the latest news stories about Transenterix Inc that investors may wish to consider to help them evaluate TRXC as an investment opportunity.

TransEnterix (TRXC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

TransEnterix (TRXC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 29, 2020

TransEnterix to initiate Senhance Surgical System program in Netherlands

TransEnterix (TRXC) is up 9% premarket after entering into an agreement with Maastricht University Medical Center+ to lease and utilize a Senhance Surgical System, in pediatric minimally invasive surgery. The Senhance Surgical System is intended to be used for laparoscopic surgery in the abdomen, pelvis and limited uses in the thoracic cavity excluding the...

Seeking Alpha | July 27, 2020

TransEnterix Announces Maastricht University Medical Center+ in the Netherlands to Initiate Program with the Senhance Surgical System

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that Maastricht University Medical Center+ (MUMC+) has entered into an agreement to lease and utilize a Senhance® Surgical System, which would be the first hospital to acquire a Senhance to be utilized in pediatric minimally invasive surgery. “This new program i

Business Wire | July 27, 2020

TransEnterix Schedules Second Quarter Financial and Operating Results Conference Call for August 5, 2020

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release second quarter financial and operating results after the market closes on Wednesday, August 5, 2020. The Company will host a conference call to discuss these results starting at 4:30 p.m. Eastern Time the same day. The call will be concurrently webcast. To listen to the conference call on your telephone, please dial 1-855-327-6837 for domestic callers and 1-631-891-43

Business Wire | July 22, 2020

TransEnterix completes $15M equity offering

TransEnterix (TRXC) announces the closure of its public stock offering with a total gross proceeds of approximately $15M.A total of 42,857,142 shares of common stock were issued including the full exercise of underwriters' over-allotment. Net proceeds were ~$13.7M.Net proceeds will fund working capital and general corporate purposes....

Seeking Alpha | July 6, 2020

Read More 'TRXC' Stories Here

TRXC Price Returns

1-mo 24.61%
3-mo 5.85%
6-mo -63.33%
1-year -96.24%
3-year -95.16%
5-year -98.87%
YTD -70.07%
2019 -95.00%
2018 17.10%
2017 48.46%
2016 -47.58%
2015 -14.78%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8088 seconds.